270 related articles for article (PubMed ID: 31763796)
1. A Cell Membrane-Targeting Self-Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback.
Ma W; Sha SN; Chen PL; Yu M; Chen JJ; Huang CB; Yu B; Liu Y; Liu LH; Yu ZQ
Adv Healthc Mater; 2020 Jan; 9(1):e1901100. PubMed ID: 31763796
[TBL] [Abstract][Full Text] [Related]
2. A ratiometric theranostic probe for tumor targeting therapy and self-therapeutic monitoring.
Li SY; Cheng H; Xie BR; Qiu WX; Song LL; Zhuo RX; Zhang XZ
Biomaterials; 2016 Oct; 104():297-309. PubMed ID: 27475726
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy.
Cheng H; Zheng RR; Fan GL; Fan JH; Zhao LP; Jiang XY; Yang B; Yu XY; Li SY; Zhang XZ
Biomaterials; 2019 Jan; 188():1-11. PubMed ID: 30312907
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication.
Song W; Kuang J; Li CX; Zhang M; Zheng D; Zeng X; Liu C; Zhang XZ
ACS Nano; 2018 Feb; 12(2):1978-1989. PubMed ID: 29420012
[TBL] [Abstract][Full Text] [Related]
5. Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy.
Jia HR; Jiang YW; Zhu YX; Li YH; Wang HY; Han X; Yu ZW; Gu N; Liu P; Chen Z; Wu FG
J Control Release; 2017 Jun; 255():231-241. PubMed ID: 28442408
[TBL] [Abstract][Full Text] [Related]
6. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
7. Ratiometric theranostic nanoprobe for pH imaging-guided photodynamic therapy.
Cheng H; Fan GL; Fan JH; Zhao LP; Zheng RR; Yu XY; Li SY
Nanoscale; 2019 May; 11(18):9008-9014. PubMed ID: 31020984
[TBL] [Abstract][Full Text] [Related]
8. Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy.
Cheng H; Fan JH; Zhao LP; Fan GL; Zheng RR; Qiu XZ; Yu XY; Li SY; Zhang XZ
Biomaterials; 2019 Aug; 211():14-24. PubMed ID: 31078049
[TBL] [Abstract][Full Text] [Related]
9. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
Zhao N; Wu B; Hu X; Xing D
Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
[TBL] [Abstract][Full Text] [Related]
10. A versatile bacterial membrane-binding chimeric peptide with enhanced photodynamic antimicrobial activity.
Zhang AN; Wu W; Zhang C; Wang QY; Zhuang ZN; Cheng H; Zhang XZ
J Mater Chem B; 2019 Feb; 7(7):1087-1095. PubMed ID: 32254776
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy.
Zhang C; Gao F; Wu W; Qiu WX; Zhang L; Li R; Zhuang ZN; Yu W; Cheng H; Zhang XZ
ACS Nano; 2019 Oct; 13(10):11249-11262. PubMed ID: 31566945
[TBL] [Abstract][Full Text] [Related]
12. Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy.
Um W; Park J; Ko H; Lim S; Yoon HY; Shim MK; Lee S; Ko YJ; Kim MJ; Park JH; Lim DK; Byun Y; Kwon IC; Kim K
Biomaterials; 2019 Dec; 224():119494. PubMed ID: 31542518
[TBL] [Abstract][Full Text] [Related]
13. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
14. Plasma membrane-anchorable photosensitizing nanomicelles for lipid raft-responsive and light-controllable intracellular drug delivery.
Jia HR; Zhu YX; Xu KF; Liu X; Wu FG
J Control Release; 2018 Sep; 286():103-113. PubMed ID: 30026079
[TBL] [Abstract][Full Text] [Related]
15. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
16. Specific light-up pullulan-based nanoparticles with reduction-triggered emission and activatable photoactivity for the imaging and photodynamic killing of cancer cells.
Xia J; Zhang L; Qian M; Bao Y; Wang J; Li Y
J Colloid Interface Sci; 2017 Jul; 498():170-181. PubMed ID: 28324723
[TBL] [Abstract][Full Text] [Related]
17. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo.
Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784
[TBL] [Abstract][Full Text] [Related]
18. A black phosphorus/manganese dioxide nanoplatform: Oxygen self-supply monitoring, photodynamic therapy enhancement and feedback.
Liu J; Du P; Liu T; Córdova Wong BJ; Wang W; Ju H; Lei J
Biomaterials; 2019 Feb; 192():179-188. PubMed ID: 30453214
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy.
Li J; Wang X; Zheng D; Lin X; Wei Z; Zhang D; Li Z; Zhang Y; Wu M; Liu X
Biomater Sci; 2018 Jun; 6(7):1834-1845. PubMed ID: 29786715
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid-loaded fullerene nanoparticles for in vitro and in vivo photodynamic therapy.
Li Z; Pan LL; Zhang FL; Zhu XL; Liu Y; Zhang ZZ
Photochem Photobiol; 2014; 90(5):1144-9. PubMed ID: 24913433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
